目的探讨大肠癌伴转移性肝癌的门静脉的特点。
Objective To investigate the characteristic of portal vein in the colorectal cancer with liver metastasis.
目的评价螺旋CT门静脉成像对门静脉的显示能力。
Objective To assess the ability of CTA for displaying the portal vein.
在留取再灌注后的标本时测量肝动脉和门静脉的血流。
Hepatic artery and PV blood flows were measured at post reperfusion collection times.
门静脉门静脉的，门静脉系统的，与门静脉系统有关的。
门静脉：门静脉的，门静脉系统的，与门静脉系统有关的。
结果为：①TAE后门静脉血流速度及血流量均较栓塞前增加，而门静脉的内径无明显改变；
The results were: (l)After TAE, portal venous flow and velocity were increased, but portal venous diameter had no significant change.
结论超声可以对门静脉的血流方向和流速曲线作出准确评估，对门静脉的通畅性诊断价值优于CT。
Conclusion Ultrasound has a high value in evaluation of direction and wave pattern of portal vein flow, and has higher accuracy in detection of portal vein patency than ct.
本文应用彩色多普勒对23例原发性肝细胞癌(HCC)患者肝动脉栓塞术(TAE)前后门静脉的血流动力学变化进行了研究。
Changes of portal venous hemodynamics after transcatheter hepatic artery embolization (TAE) were studied in 23 hepatocellular carcinoma (HCC) patients using the color Doppler system.
《国际肝病》：本次会议在你主持的一节，有一个问题：门静脉血栓形成：抗凝治疗？是或否？您对此有什么看法？
Hepatology Digest: at a session you are moderating at this meeting, there is a question: Portal vein thrombosis: Anticoagulation? Yes or No? What is your opinion about that?
评估了大小胰岛细胞在低氧状态下的胰岛素分泌和模拟门静脉内移植环境量化了细胞死亡。
We assessed insulin secretion of large and small islets and quantified cell death during hypoxic conditions simulating the intraportal transplant environment.
如果病人很可靠，并且没有其他抗凝治疗禁忌症，如果已分离出特定的门静脉血栓形成病人，那它就可以是最好的选择。
If the patient is very reliable and has no other contra-indications for anticoagulation, then it could be the best choice for that particular patient if they have isolated portal vein thrombosis.
方法回顾性总结此术式治疗门静脉高压症上消化道出血56例的疗效。
Methods a retrospective summary was made on 56 cases of portal hypertension with hemorrhage treated by the combined operation.
此外，门静脉肌成纤维细胞可以产生更多且更容易伸长的应力纤维。
In addition the portal myofibroblasts form more stress fibres and are more elongated.
方法回顾分析了12例患者，脾切除术后门静脉系统血栓形成患者的超声检查资料。
Methods The ultrasonographic data of 12 cases of portal vein thrombosis after splenectomy were analyzed retrospectively.
目的探讨脾脏巨噬细胞在门静脉高压症脾功能亢进发生中的作用。
Objective To investigate the role of splenic macrophage in the occurrence of hypersplenism in patients with portal hypertension.
目的探讨门静脉高压性胃病的发病机理。
Objective To investigate the pathogenesis of portal hypertensive gastropathy.
目的利用MSCT对正常人的肝门静脉和脾静脉进行研究与测量，求得其解剖学数据，供临床参考。
Objective to study normal hepatic portal veins by means of multi-slice ct (MSCT) so as to provide anatomical data for clinical reference.
穿刺左中支门静脉，以不同浓度、剂量和推注速度的NBCA栓塞该血管。
Selective puncture to embolize the left-middle portal vein with the different concentration, dosage and the injection speed of NBCA.
目的探讨门静脉栓塞的安全范围及白芨微球作为门静脉栓塞剂的可行性与有效性。
Objective To discuss the safety limit of portal vein embolization, to evaluate the feasibility and efficacy of Bletilla microsphere used as an embolic agent for portal vein.
结果门静脉海绵样变性的二维超声具有特征性声像，结合彩色多普勒超声可以更加明确诊断。
Results Two-dimensional ultrasonography had characteristic imaging features for diagnosing CTPV which were further definitely diagnosed with color Doppler ultrasonography.
方法：49 例无手术指征肝癌患者，行单纯肝动脉栓塞与在肝动脉栓塞的基础上行肝门静脉化疗的对照研究。
Methods: 49 patients with late liver carcinoma were treated with embolism of hepatic artery and combined with chemotherapy through portal vein were reported.
目的观察HO CO系统在肝硬化病人肝组织中的表达及与门静脉压力的关系，以探讨其在肝硬化门脉高压中的作用。
Purpose To observe the relationship between portal pressure and the expression of HO-CO system in liver of patients with hepatic cirrhosis and the effect on portal hypertension in hepatic cirrhosis.
目的研究经颈静脉途径肝内门体静脉内支架分流术TIPS S术后肝性脑病的发生与门静脉血流方向的关系。
Objective: to study the relationship between hepatic encephalopathy and blood flow direction of intra hepatic portal vein after transjugular intrahepatic portosystemic stent shunt (TIPSS).
及时门静脉分流手术是唯一的治疗方法。
胃静脉曲张出血是导致门静脉高压死亡的主要原因。
Bleeding from gastric varices is a major cause of death in portal hypertension.
结论：经间接门静脉灌注可作为直接门静脉灌注的一个补充手段应用于肝肿瘤的“双灌注”治疗。
CONCLUSIONS Intra indirect portal vein perfusion can be apply to dual perfusion treatment of liver tumors as a supplementing means of portal vein perfusion.
结论：经间接门静脉灌注可作为直接门静脉灌注的一个补充手段应用于肝肿瘤的“双灌注”治疗。
CONCLUSIONS Intra indirect portal vein perfusion can be apply to dual perfusion treatment of liver tumors as a supplementing means of portal vein perfusion.
应用推荐